SITC
“The return of Winter School affirms the society’s commitment to develop the next generation of leaders in immuno-oncology who will undoubtedly advance cancer immunotherapy in the lab and clinic,” said SITC President Mario Sznol, MD. “By continuing to invest in the education and..."
MILWAUKEE (PRWEB) September 22, 2020
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the third annual Cancer Immunotherapy Winter School, a comprehensive educational program, being held virtually on Feb. 22–24, 2021.
The SITC Cancer Immunotherapy Winter School will feature leading experts in the field who will provide attendees with a deep understanding of the core principles and clinical applications of tumor immunology and cancer immunotherapy. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks allowing participants to tailor their experience by selecting the educational path most relevant to their learning goals.
“The return of Winter School affirms the society’s commitment to develop the next generation of leaders in immuno-oncology who will undoubtedly advance cancer immunotherapy in the lab and clinic,” said SITC President Mario Sznol, MD. “By continuing to invest in the education and career development of those in the field, we can accomplish SITC’s primary goal of improving the lives of cancer patients.”
During the virtual program, Cancer Immunotherapy Winter School participants will learn: core principles of tumor immunology and cancer immunotherapy; recent advancements in drug and biomarker technologies and their clinical application; and grant writing to obtain research funding.
In addition to deepening their understanding of integral facets of the field of cancer immunotherapy, attendees will also be able to expand their professional network, developing new relationships with faculty and other thought leaders in this intimate setting through small group virtual breakout sessions.
“This is a terrific opportunity for researchers and clinicians, new to the field, to not only deepen their understanding cancer immunotherapy, but to also forge new relationships with colleagues from around the world,” said SITC Cancer Immunotherapy Winter School Co-Organizer Leisha A. Emens, MD, PhD. “Collaboration is a critical component to achieving scientific progress, and this program will seek to lay the foundation for new professional relationships that could blossom into cross-institutional teams in the future.”
The Cancer Immunotherapy Winter School will take place online Feb. 22–24, 2021. Registration rates and the program schedule are available on SITC Cancer Immunotherapy CONNECT.
About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.
